Release Date: 01/03/13 11:02 Summary: Greenmount Results Price Sensitive: Yes Download Document 1.43MB Download
NEU Neuren Pharmaceuticals dips after pediatric Angelman Syndrome Phase 2 trial results fail to impress
Week 32 Wrap: AI is clearly overhyped – but did we see ‘bubble’ burst already? Plus RBA decision; Japan’s wild week & Google ruling